Mediator removal with CRRT: Complement and cytokines

American Journal of Kidney Diseases

Volumn 30, Issue 5 SUPPL., 1997, Pages

  Silvester, W ^a  

^a AUSTIN HEALTH   (Australia)

Author keywords

Complement; Cytokines; Hemofiltration; Sepsis

Indexed keywords

COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; COMPLEMENT FACTOR D; CYTOKINE; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; POLYACRYLONITRILE; POLYAMIDE; POLYSULFONE; TUMOR NECROSIS FACTOR ALPHA;

ADSORPTION; COMPLEMENT SYSTEM; CONFERENCE PAPER; DIALYSIS MEMBRANE; HEMOFILTRATION; HUMAN; NONHUMAN; SEPSIS;

EID: 0030700791     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0272-6386(97)90541-2     Document Type: Conference Paper

References (37)

1. A Gomez R Wang H Unruh Hemofiltration reverses left ventricular dysfunction during sepsis in dogs Anesthesiology 73 1990 671 685
2. AF Grootendorst EF van Bommel B van der Hoven LA van Leengoed AL van Osta High volume hemofiltration improves right ventricular function in endotoxin-induced shock in the pig Intensive Care Med 18 1992 235 240
3. PA Lee JR Matson RW Pryor LB Hinshaw Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus -induced septicaemia in immature swine Crit Care Med 21 1993 914 924
4. J Kellum J Johnson P Palevsky Diffusive versus convective therapy: Effects on mediators of inflammation in patients with systemic inflammatory response syndrome Am J Resp Crit Care Med 155 1997 A926 (abstr)
5. M Schetz P Ferdinande G Van den Berghe C Verwaest P Lauwers Removal of pro-inflammatory cytokines with renal replacement therapy: Sense or nonsense? Intensive Care Med 21 1995 169 176
6. P Reetze-Bonorden J Bohler E Keller Drug dosage in patients during continuous renal replacement therapy Pharmacokinetic and therapeutic considerations ed 2 Clinical Pharmacokinetics 24 1993 362 379
7. C Lee T Marbury Drug therapy in patients undergoing haemodialysis: Clinical pharmacokinetic considerations Clinical Pharmacokinetics 9 1984 42 66
8. G Levy Pharmacokinetics in renal disease Am J Med 62 1977 461 465
9. P Rogiers H Zhang N Smail D Pauwels J Vincent Effects of CVVH on regional blood flow and nitric oxide production in canine endotoxic shock SCCM Annual Scientific Meeting, CRRT Workshop San Diego, CA 1997
10. AF Grootendorst EF van Bommel LA van Leengoed AR van Zanten HJ Huipen AB Groeneveld Infusion of ultrafiltrate from endotoxemic pigs depresses myocardial performance in normal pigs J Crit Care 8 1993 161 169
11. DR Spriggs ML Sherman H Michie Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion A phase I and pharmacologic study ed 2 J Natl Cancer Inst 80 1988 1039 1044
12. MR Pinsky JL Vincent J Deviere M Alegre RJ Kahn E Dupont Serum cytokine levels in human septic shock Relation to multiple-system organ failure and mortality ed 2 Chest 103 1993 565 575
13. G Lonnemann R Schindler C Dinarello K Koch Removal of circulating cytokines by hemodialysis membranes in vitro K Faist D Meakins D Schildberg Host Defense Dysfunction in Trauma, Shock and Sepsis 1993 Springer-Verlag Heidelberg, Germany 613 623
14. P Barrera EM Janssen PN Demacker JF Wetzels JW van der Meer Removal of interleukin-1 beta and tumor necrosis factor from human plasma by in vitro dialysis with polyacrylonitrile membranes Lymphokine Cytokine Res 11 1992 99 104
15. M Nagaki RD Hughes JYN Lau R Williams Removal of endotoxin and cytokines by adsorbents and the effects of plasma protein binding Int J Artif Organs 14 1991 43 50
16. A Brown R Mehta Effect of CAVH membranes on transmembrane flux of TNF-alpha J Am Soc Nephrol 2 1991 A316 (abstr)
17. S Goldfarb TA Golper Proinflammatory cytokines and hemofiltration membranes J Am Soc Nephrol 5 1994 228 232
18. EF van Bommel CJ Hesse NH Jutte R Zietse HA Bruining W Weimar Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: A laboratory and clinical study Contrib Nephrol 116 1995 62 75
19. JN Hoffmann WH Hartl R Deppisch E Faist M Jochum D Inthorn Hemofiltration in human sepsis: Evidence for elimination of immunomodulatory substances Kidney Int 48 1995 1563 1570
20. JN Hoffmann WH Hartl R Deppisch E Faist M Jochum D Inthorn Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis Intensive Care Med 22 1996 1360 1367
21. AB Millar L Armstrong J van der Linden Cytokine production and hemofiltration in children undergoing cardiopulmonary bypass Ann Thorac Surg 56 1993 1499 1502
22. D Journois P Pouard WJ Greeley P Mauriat P Vouhe D Safran Hemofiltration during cardiopulmonary bypass in pediatric cardiac surgery Effects on hemostasis, cytokines, and complement components ed 2 Anesthesiology 81 1994 1181 1189
23. W Silvester P Honore E Sieffert Interleukins 6 and 8, tumour necrosis factor alpha and complement D clearance by polyacrylonitrile and polysulphone membranes during haemofiltration in critically ill patients Blood Purif 15 1997 A127
24. CE Hack JH Nuijens RJ Felt-Bersma Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis Am J Med 86 1989 20 26
25. CE Hack ER De Groot RJ Felt-Bersma Increased plasma levels of interleukin-6 in sepsis Blood 74 1989 1704 1710
26. N Haeffner-Cavaillon JM Cavaillon M Laude MD Kazatchkine C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes J Immunol 139 1987 794 799
27. S Okusawa CA Dinarello KB Yancey C5a induction of human interleukin 1 Synergistic effect with endotoxin or interferon-gamma ed 2 J Immunol 139 1987 2635 2640
28. R Schindler JA Gelfand CA Dinarello Recombinant C5a stimulates transcription rather than translation of interleukin-1 (IL-1) and tumor necrosis factor: Translational signal provided by lipopolysaccharide or IL-1 itself Blood 76 1990 1631 1638
29. S Andreasson S Gothberg H Berggren A Bengtsson E Eriksson B Risberg Hemofiltration modifies complement activation after extracorporeal circulation in infants Ann Thorac Surg 56 1993 1515 1517
30. K Saatvedt H Lindberg OR Geiran Ultrafiltration after cardiopulmonary bypass in children: Effects on hemodynamics, cytokines and complement Cardiovasc Res 31 1996 596 602
31. D Journois D Israel-Biet P Pouard High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children Anesthesiology 85 1996 965 976
32. N Haeffner-Cavaillon N Roussellier O Ponzio Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass J Thorac Cardiovasc Surg 98 1989 1100 1106
33. P Lesavre H Muller-Eberhard Mechanism of action of factor D of the alternative complement pathway J Exp Med 148 1978 1498 1509
34. M Pascual G Steiger J Estreicher K Macon JE Volanakis JA Schifferli Metabolism of complement factor D in renal failure Kidney Int 34 1988 529 536
35. Y Gasche M Pascual PM Suter H Favre JC Chevrolet JA Schifferli Complement depletion during haemofiltration with polyacrilonitrile membranes Nephrol Dial Transplant 11 1996 117 119
36. D Metcalf N Nicola The hemopoietic colony-stimulating factors From cell biology to clinical application 1995 Cambridge University Press Cambridge, United Kingdom
37. S Basu A Dunn M Marino Increased tolerance to endotoxin by granulocyte-macrophage colony-stimulating factor (GM-CSF)-deficient mice J Immunol 159 1997 1412 1417